Hecht Beth sold XERS
January 31, 2026 · Form 4 insider transaction
Hecht Beth sold 98,375 shares of Xeris Biopharma Holdings, Inc. at $7.36 per share, a transaction worth $724.0K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
98,375
Price
$7.36
Total value
$724.0K
InsiderHecht Beth
Role—
SecurityCommon Stock
Transaction codeF: Shares withheld for taxes
Transaction dateJanuary 31, 2026
Filing dateFebruary 2, 2026
Shares owned after1,331,021
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of restricted stock units vested as of January 31, 2026.